表紙
市場調查報告書

人體生長荷爾蒙(hGH)的全球市場:各應用領域(生長激素缺乏症,透納氏症,特發性矮小症,普拉達威利症候群,小於胎齡兒),地區 2014年∼2025

Human Growth Hormone Market Size, Share & Trends Analysis Report By Application (Growth Hormone Deficiency, Turner Syndrome), By Distribution Channel, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 600786
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
人體生長荷爾蒙(hGH)的全球市場:各應用領域(生長激素缺乏症,透納氏症,特發性矮小症,普拉達威利症候群,小於胎齡兒),地區 2014年∼2025 Human Growth Hormone Market Size, Share & Trends Analysis Report By Application (Growth Hormone Deficiency, Turner Syndrome), By Distribution Channel, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年02月05日內容資訊: 英文 120 Pages
簡介

生長激素缺乏症,普拉達威利症候群,原發性矮小症,小於胎齡兒(SGA)是治療使用生長激素(GH)的疾病。克雅氏病,慢性腎臟病,SHOX遺傳基因單套缺失症候群,關於努南氏症候群等其他的適應症也接受核准。全球人體生長荷爾蒙(hGH)市場預計2025年達到71億美元。腦垂體功能不全的案例增加,人體生長荷爾蒙的使用增加,預計今後數年促進市場成長。

本報告提供全球人體生長荷爾蒙(hGH)市場相關調查,市場概要,各應用領域、地區的市場趨勢,市場規模的變化與預測,市場成長要素分析,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 摘要整理

  • 市場概述

第2章 調查方法

  • 資訊採購
  • 資料分析

第3章 人體生長荷爾蒙(hGH)市場趨勢與範圍

  • 市場區隔和範圍
  • 滲透與成長預測製圖
  • 人體生長荷爾蒙 - SWOT分析
  • 產業分析 - 波特的五力分析
  • 競爭情形:市場地位分析

第4章 人體生長荷爾蒙(hGH)市場趨勢分析與預測:各應用領域

  • 市場分析:各應用領域
  • 生長激素缺乏症
  • 透納氏症
  • 原發性矮小症
  • 普拉達威利症候群
  • 小於胎齡兒
  • 其他

第5章 人體生長荷爾蒙(hGH)市場趨勢分析與預測:各地區

  • 市場分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
  • 亞太地區
    • 日本
    • 中國
  • 中南美
    • 巴西
    • 墨西哥
  • 中東、非洲
    • 南非

第6章 競爭情形

  • 策略架構
  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-2-68038-057-6

The global human growth hormone market size is expected to reach a value of USD 8.5 billion by 2027, registering a CAGR of 8.2% over the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel therapies, increasing R&D activities, and rising awareness for the diagnosis and treatment of growth hormone (GH) disorders are expected to drive the market over the forecast period.

Key players operating in the market are involved in extensive R&D activities for the development of novel GH therapies to strengthen their position in the market. For instance, in October 2019, VISEN Pharmaceuticals, a joint venture of Denmark-based Ascendis Pharma A/S, received approval from China National Drug Administration (NMPA) for its new drug (IND) application to start Phase III clinical study of TransCon hGH. Furthermore, two South Korean companies, Genexine Inc. and Handok Inc., are conducting a Phase II clinical trial study on GX-H9, a recombinant human GH for the treatment of adult and pediatric GH deficiency.

Furthermore, increase in the number of regulatory approvals and launch of novel hGH therapies are expected to fuel the market over the forecast period. For instance, in January 2018, Ferring Pharmaceuticals Inc., a Switzerland-based pharmaceutical company, received United States Food and Drug Administration (USFDA) approval for its new recombinant hGH, Zomacton (somatropin) indicated for the treatment of adult patients with GH deficiency.

Various government and private organizations have been undertaking initiatives and programs to spread awareness about GH deficiency and facilitate timely diagnosis and treatment. Nonprofit organizations such as Human Growth Foundation are engaged in providing research support and spreading awareness about GH deficiency and its treatment. Such initiatives are expected to drive the demand for hGH treatment therapies.

Further key findings from the study suggest:

  • GH deficiency was the largest application segment in 2019 owing to increase in regulatory approvals and launch of novel therapies
  • Rising awareness about GH deficiency, coupled with increasing hospital visits for its treatment, is expected to drive the hospital distribution channel segment
  • North America dominated the human growth hormone market with the largest share in 2019. This is attributed to favorable reimbursement scenario, high awareness, and the presence of major players in the region
  • Asia Pacific is projected to witness a lucrative CAGR over the forecast period owing to increasing penetration of key players with their new growth hormone therapies

The key players include Novo Nordisk A/S; Pfizer Inc.; Eli Lilly and Company; Sandoz International GmbH (Novartis AG); Merck KGaA; Genentech, Inc. (Roche); Ferring Pharmaceuticals; Teva Pharmaceutical Industries, Ltd; and Ipsen.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Market definition
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information analysis
    • 1.4.1 Data analysis models
  • 1.5 Market formulation & data visualization
  • 1.6 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Human Growth Hormone (hGH) Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Increasing R&D investments
      • 3.3.1.2 Introduction of novel therapies
      • 3.3.1.3 Increasing awareness regarding GH deficiency
      • 3.3.1.4 Robust pipeline
      • 3.3.1.5 Strategic initiatives by key players
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Adverse effects related to hormone therapies
      • 3.3.2.2 Stringent regulatory scenario
      • 3.3.2.3 High treatment cost
    • 3.3.3 Industry challenges
  • 3.4 Human Growth Hormone (hGH) Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
      • 3.4.1.1 Supplier Power
      • 3.4.1.2 Buyer Power
      • 3.4.1.3 Substitution Threat
      • 3.4.1.4 Threat from new entrants
      • 3.4.1.5 Competitive Rivalry
    • 3.4.2 PESTEL Analysis
      • 3.4.2.1 Political Landscape
      • 3.4.2.2 Environmental Landscape
      • 3.4.2.3 Social landscape
      • 3.4.2.4 Technology landscape
      • 3.4.2.5 Legal Landscape
    • 3.4.3 Major deals and strategic alliances analysis
      • 3.4.3.1 Joint ventures
      • 3.4.3.2 Mergers and acquisitions
      • 3.4.3.3 Licensing and partnership
      • 3.4.3.4 Technology collaborations
      • 3.4.3.5 Strategic Divestments
    • 3.4.4 Market entry strategies

Chapter 4 Human Growth Hormone (hGH) Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Vendor Landscape
    • 4.2.1 List of key distributors and channel partners
    • 4.2.2 Key company market share analysis, 2019
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
    • 4.3.2 Competitive dashboard analysis
  • 4.4 Private Companies
    • 4.4.1 List of key emerging companies
    • 4.4.2 Regional network map
    • 4.4.3 Company market position analysis

Chapter 5 Human Growth Hormone (hGH) Market: Application Estimates And Trend Analysis

  • 5.1 Definition & Scope
  • 5.2 Application Market Share Analysis, 2019 & 2027
  • 5.3 Segment Dashboard
  • 5.4 Global Human Growth Hormone (hGH) Market, by Application, 2016 to 2027
  • 5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 5.5.1 Growth Hormone Deficiency
      • 5.5.1.1 Growth Hormone Deficiency Market Estimates and Forecasts, 2016 to 2027 (USD Million)
      • 5.5.1.2 Adult Growth Hormone Deficiency
      • 5.5.1.2.1 Adult Growth Hormone Deficiency Market Estimates and Forecasts, 2016 to 2027 (USD Million)
      • 5.5.1.3 Pediatric Growth Hormone Deficiency
      • 5.5.1.3.1 Pediatric Growth Hormone Deficiency Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.2 Turner Syndrome
      • 5.5.2.1 Turner Syndrome Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.3 Idiopathic Short Stature
      • 5.5.3.1 Idiopathic Short Stature Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.4 Prader-Willi Syndrome
      • 5.5.4.1 Prader-Willi Syndrome Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.5 Small for Gestational Age
      • 5.5.5.1 Small for Gestational Age Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.6 Others
      • 5.5.6.1 Others Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 6 Human Growth Hormone (hGH) Market: Distribution Channel Estimates And Trend Analysis

  • 6.1 Definition & Scope
  • 6.2 Distribution Channel Market Share Analysis, 2019 & 2027
  • 6.3 Segment Dashboard
  • 6.4 Global Human Growth Hormone (hGH) Market, by Distribution Channel, 2016 to 2027
  • 6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 6.5.1 Hospital Pharmacy
      • 6.5.1.1 Hospital Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 6.5.2 Retail Pharmacy
      • 6.5.2.1 Retail Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 6.5.3 Online Pharmacy
      • 6.5.3.1 Online Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 6.5.4 Specialty Pharmacy
      • 6.5.4.1 Specialty Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 7 Human Growth Hormone (hGH) Market: Regional Estimates & Trend Analysis

  • 7.1 Regional Market Snapshot
  • 7.2 Regional Market Share and Leading Players, 2019
    • 7.2.1 North America
    • 7.2.2 Europe
    • 7.2.3 Latin America
    • 7.2.4 Asia Pacific
    • 7.2.5 Middle East & Africa
  • 7.3 Market Share Analysis by Country, 2019
    • 7.3.1 North America
      • 7.3.1.1 U.S.
      • 7.3.1.2 Canada
    • 7.3.2 Europe
      • 7.3.2.1 U.K.
      • 7.3.2.2 Germany
      • 7.3.2.3 Spain
      • 7.3.2.4 France
      • 7.3.2.5 Italy
      • 7.3.2.6 Russia
    • 7.3.3 Latin America
      • 7.3.3.1 Brazil
      • 7.3.3.2 Mexico
      • 7.3.3.3 Argentina
    • 7.3.4 Asia Pacific
      • 7.3.4.1 Japan
      • 7.3.4.2 China
      • 7.3.4.3 India
      • 7.3.4.4 South Korea
      • 7.3.4.5 Singapore
      • 7.3.4.6 Australia
    • 7.3.5 Middle East & Africa
      • 7.3.5.1 South Africa
      • 7.3.5.2 Saudi Arabia
      • 7.3.5.3 UAE
  • 7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.4.1 North America
    • 7.4.2 Europe
    • 7.4.3 Latin America
    • 7.4.4 Asia Pacific
    • 7.4.5 Middle East & Africa
  • 7.5 Market Size & Forecasts, and Trend Analysis, 2019 to 2027
    • 7.5.1 North America
      • 7.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.1.2 U.S.
      • 7.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.1.3 Canada
      • 7.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.2 Europe
      • 7.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.2.2 U.K.
      • 7.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.3 Germany
      • 7.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.4 Spain
      • 7.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.5 France
      • 7.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.6 Italy
      • 7.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.7 Russia
      • 7.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.3 Latin America
      • 7.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.3.2 Brazil
      • 7.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.3.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.3.3 Mexico
      • 7.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.3.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.3.4 Argentina
      • 7.5.3.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.3.4.2 Argentina Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.4 Asia Pacific
      • 7.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.4.2 Japan
      • 7.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.2.2 Japan Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.3 China
      • 7.5.4.3.1 China Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.3.2 China Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.4 India
      • 7.5.4.4.1 India Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.4.2 India Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.5 South Korea
      • 7.5.4.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.5.2 South Korea Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.6 Singapore
      • 7.5.4.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.6.2 Singapore Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.7 Australia
      • 7.5.4.7.1 Australia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.7.2 Australia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.5 Middle East & Africa
      • 7.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.5.2 South Africa
      • 7.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.5.3 Saudi Arabia
      • 7.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.5.4 UAE
      • 7.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)

Chapter 8 COMPANY PROFILE

  • 8.1 Company Profiles
    • 8.1.1 Novo Nordisk A/S
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product benchmarking
      • 8.1.1.4 Strategic initiatives
    • 8.1.2 Pfizer, Inc.
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product benchmarking
      • 8.1.2.4 Strategic initiatives
    • 8.1.3 Eli Lilly and Company
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product benchmarking
      • 8.1.3.4 Strategic initiatives
    • 8.1.4 Sandoz International GmbH
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product benchmarking
      • 8.1.4.4 Strategic initiatives
    • 8.1.5 Merck KGaA
      • 8.1.5.1 Company overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product benchmarking
      • 8.1.5.4 Strategic initiatives
    • 8.1.6 Genentech, Inc.
      • 8.1.6.1 Company overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Product benchmarking
      • 8.1.6.4 Strategic initiatives
    • 8.1.7 Ferring B.V.
      • 8.1.7.1 Company overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product benchmarking
      • 8.1.7.4 Strategic initiatives
    • 8.1.8 Ipsen
      • 8.1.8.1 Company overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product benchmarking
      • 8.1.8.4 Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America human growth hormone (hGH) market, by country, 2016 - 2027 (USD Million)
  • Table 4 North America human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 5 North America human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 6 North America human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 7 U.S. human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 8 U.S. human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 9 U.S. human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 10 Canada human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 11 Canada human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 12 Canada human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 13 Europe human growth hormone (hGH) market, by country, 2016 - 2027 (USD Million)
  • Table 14 Europe human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 15 Europe human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 16 Europe human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 17 Germany human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 18 Germany human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 19 Germany human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 20 U.K. human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 21 U.K. human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 22 U.K. human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 23 France human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 24 France human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 25 France human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 26 Italy human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 27 Italy human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 28 Italy human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 29 Spain human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 30 Spain human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 31 Spain human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 32 Russia human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 33 Russia human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 34 Russia human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 35 Asia Pacific human growth hormone (hGH) market, by country, 2016 - 2027 (USD Million)
  • Table 36 Asia Pacific human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 37 Asia Pacific human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 38 Asia Pacific human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 39 Japan human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 40 Japan human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 41 Japan human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 42 China human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 43 China human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 44 China human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 45 India human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 46 India human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 47 India human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 48 Australia human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 49 Australia human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 50 Australia human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 51 South Korea human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 52 South Korea human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 53 South Korea human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 54 Singapore human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 55 Singapore human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 56 Singapore human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 57 Latin America human growth hormone (hGH) market, by country, 2016 - 2027 (USD Million)
  • Table 58 Latin America human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 59 Latin America human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 60 Latin America human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 61 Brazil human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 62 Brazil human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 63 Brazil human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 64 Mexico human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 65 Mexico human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 66 Mexico human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 67 Argentina human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 68 Argentina human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 69 Argentina human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 70 MEA human growth hormone (hGH) market, by country, 2016 - 2027 (USD Million)
  • Table 71 MEA human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 72 MEA human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 73 MEA human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 74 South Africa human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 75 South Africa human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 76 South Africa human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 77 Saudi Arabia human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 78 Saudi Arabia human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 79 Saudi Arabia human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 80 UAE human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 81 UAE human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 82 UAE human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Human Growth Hormone (hGH) market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Human growth hormone (hGH) market snapshot (2019)
  • Fig. 9 Human growth hormone (hGH) market: Segment snapshot (2019)
  • Fig. 10 Competitive Insights (2019)
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Human growth hormone (hGH) market driver impact
  • Fig. 15 Human growth hormone (hGH) market restraint impact
  • Fig. 16 Human growth hormone (hGH) industry challenges
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 19 Strategic alliance analysis
  • Fig. 20 Recent developments & impact analysis, by key market participants
  • Fig. 21 Key company market share analysis, 2019
  • Fig. 22 Company market position analysis
  • Fig. 23 Definition and scope, by product
  • Fig. 24 Product market share analysis, 2019 & 2027
  • Fig. 25 Segment dashboard
  • Fig. 26 Global human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Fig. 27 Growth Hormone Deficiency market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 28 Adult Growth Hormone Deficiency market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 29 Pediatric Hormone Deficiency market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 30 Turner Syndrome market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 31 Idiopathic Short Stature market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 32 Prader-Willi Syndrome market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 33 Small for Gestational Age market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 34 Others market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 35 Global human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Fig. 36 Hospital pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 37 Retail pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 38 Online pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 39 Specialty pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 40 Human growth hormone (hGH) market: Snapshot, 2019
  • Fig. 41 North America human growth hormone (hGH) market share and leading players, 2019
  • Fig. 42 Europe human growth hormone (hGH) market share and leading players, 2019
  • Fig. 43 Asia Pacific human growth hormone (hGH) market share and leading players, 2019
  • Fig. 44 Latin America human growth hormone (hGH) market share and leading players, 2019
  • Fig. 45 Middle East and Africa human growth hormone (hGH) market share and leading players, 2019
  • Fig. 46 North America market share analysis by country, 2019
  • Fig. 47 Europe market share analysis by country, 2019
  • Fig. 48 Asia Pacific market share analysis by country, 2019
  • Fig. 49 Latin America market share analysis by country, 2019
  • Fig. 50 Middle East and Africa market share analysis by country, 2019
  • Fig. 51 North America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 52 Europe SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 53 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 54 Latin America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 55 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 56 North America market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 57 U.S. market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 58 Canada market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 59 Europe market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 60 U.K. market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 61 Germany market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 62 Spain market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 63 France market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 64 Italy market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 65 Russia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 66 Asia Pacific market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 67 China market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 68 Japan market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 69 India market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 70 Australia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 71 South Korea market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 72 Singapore market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 73 Latin America market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 74 Brazil market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 75 Mexico market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 76 Argentina market size, & forecasts and trend analysis, 2016 to 2027 (USD Million))
  • Fig. 77 Middle East and Africa market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 78 South Africa market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 79 Saudi Arabia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 80 UAE market size, & forecasts and trend analysis, 2016 to 2027(USD Million)